Dual Therapeutics is an oncology start-up company developing novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. Founded in 2013, the company's technology is based on research developed and exclusively licensed from the Mount Sinai School of Medicine and Case Western Reserve University. Currently, Dual Therapeutics is at the development compound nomination milestone and expects to file its IND application and begin clinical studies in 2015.
View Top Employees from Dual Therapeutics LLC| Website | http://www.dualtherapeutics.com |
| Revenue | $4 million |
| Funding | $6.4 million |
| Employees | View employees |
| Founded | 2013 |
| Address | 20600 Chagrin Blvd Ste 210, Cleveland, Ohio 44122, US |
| Phone | (216) 455-3200 |
| Industry | Medical Practices, Hospitals & Clinics, Drug Discovery, Healthcare, Therapeutic Devices |
| Competitors | Crown Bioscience, Flatiron Health, Onco Inc, Premier Cancer Centers, Vantage Oncology Now Part of The US Oncology Network |
| SIC | SIC Code 804 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62139 Companies, NAICS Code 62 Companies, NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 621 Companies |
Looking for a particular Dual Therapeutics LLC employee's phone or email?
Dual Therapeutics LLC Questions
The Dual Therapeutics LLC annual revenue was $4 million in 2024.
Dual Therapeutics LLC is based in Cleveland, Ohio.
The NAICS codes for Dual Therapeutics LLC are [62139, 62, 6213, 621399, 621].
The SIC codes for Dual Therapeutics LLC are [804, 80].
Related Companies
